Although the exact receptor at which NLG3 acts upon tumour cells has not been identified, it has been shown that the subsequent activation of focal adhesion kinase (FAK) and downstream signalling through the PI3K/AKT pathway leads to glioma cell proliferation [49]. The gene discussed is AKT1; the disease is neoplasm.